NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/13/2026
Back to search
Official data from USPTO
CONSTRUCTIVE BIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CONSTRUCTIVE BIO
ST13
US500000098771525Class
1, 5, 40, 42
Filing
98771525
Registration
8098578
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
01/13/2026
Trademark type
Word
Nice classes
1, 5, 40, 42
Filing date
09/26/2024
Registration date
01/13/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/13/2026
Last transaction
01/13/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
24
Owner location
London, GB
Examiner
HALMEN, KATHERINE E
Law office
M20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Constructive Biology Limited
Representatives
Karen L. Elbing CLARK+ELBING LLP
Technical classification
Nice Classes
Class 1Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Nucleic acid sequencesother than for medical or veterinary purposes; artificial nucleic acid sequencesother than for medical or veterinary purposes; amino acid sequencesother than for medical or veterinary purposes; artificial amino acid sequencesother than for medical or veterinary purposes; enzymes for industrial purposes; enzymes for scientific purposes; proteins for industrial purposes; bacterial preparations for industrial useother than for medical or veterinary purposes; biopolymersunprocessed polymers of amino acids and hydroxy acids; biopolymersunprocessed polymers of amino acids; biopolymersunprocessed polymers of hydroxy acids; biomoleculesnamely amino acidsother than for medical or veterinary purposes; biomoleculesnamely hydroxy acidsother than for medical or veterinary purposes; biomoleculesnamely amino acids and hydroxy acidsother than for medical or veterinary purposes; bioplastics in the nature of unprocessed plastics that derive from biological sources; synthetic bacteria for use in the manufacture of polymers and materials comprising amino acids; synthetic bacteria for use in the manufacture of polymers and materials comprising hydroxy acids; synthetic bacteria for use in the manufacture of polymers and materials comprising nucleic acid sequences; recoded bacterial genomesnucleic acid sequences with a modified genetic code that differs from the genetic code of the native speciesother than for medical or veterinary purposes; synthetic eukaryotic cells in the nature of mammalianplantyeast or other eukaryotic cells with a synthetic genome for scientificlaboratory or medical research; recoded eukaryotic genomes namelynucleic acid sequences with a modified genetic code that differs from that of the native speciesother than for medical or veterinary purposes; reagents for research purposes; bacteriophage-resistant bacteria for biomanufacturing for use in the manufacture of polymers and materials comprising amino acids; bacteriophage-resistant bacteria for biomanufacturing for use in the manufacture of polymers and materials comprising hydroxy acids; bacteriophage-resistant bacteria for biomanufacturing for use in the manufacture of polymers and materials comprising nucleic acid sequences; biochemical preparations in the nature of polypeptides containing non-proteinogenic amino acids for industrial purposes; biochemical preparations in the nature of polypeptides containing non-proteinogenic amino acids for scientific purposes; biochemical preparations in the nature of polypeptides containing non-canonical amino acids for industrial purposes; biochemical preparations in the nature of polypeptides containing non-canonical amino acids for scientific purposes
Class 5
Pharmaceuticals preparations for human and veterinary purposes namely analgesics preparationsantibiotics preparationspharmaceutical preparations for treating diabetesantidiarrheals medicinesantifungal preparationsantihypertensivesantihistaminespharmaceutical preparations for the treatment of inflammationpharmaceutical preparations for the treatment of arthritisanthelminticscardiovascular agents for medical purposesallergy medicationsdermatologicalsdiureticsanimal feed supplementshuman growth hormonesanimal growth hormonespharmaceutical preparations for treating gynaecological conditionspharmaceutical preparations for treating haematological conditionslaxativesantiendotoxin antibodies for medical purposespharmaceutical agents affecting metabolismpediculicidal shampoospharmaceutical preparations for treating nausea and vertigosleeping pills/tabletsmedical preparations containing stimulants for treating neurological disorderstranquiliserspsychotherapeutic preparations in the nature of psychotropicsvitaminspharmaceutical preparations for the treatment of oncological diseases and disorderspreparations for use in the treatment of cancer and tumoursmedicinal creams for skin carepharmaceutical preparations for the treatment of immune system related diseases and disorderspharmaceutical preparations for the treatment of endocrine related diseases and disorders; biotechnological preparations for medical and veterinary usebiotechnological pharmaceutical preparations in the form of fluid extracts for medicinal usespillsmedicated tabletscompressed medicinal lozengeselixirssyrups for medicinal preparationsmedicinal cordialssolid extractspowdered extractsconcentrationsfilled capsules and medicinal compounds in solid and liquid form for the treatment of diabetesdiarrheafungal infections/conditionshypertensioninflammationarthritishelminth infectionscardiovascular conditionsallergiesdermatological conditionsgynaecological conditionshaematological conditionsmetabolic conditionsnausea and vertigooncological diseases and disorderscancer and tumours; biopharmaceuticals for medical and veterinary usebiopharmaceutical preparations for human and veterinary purposes namely analgesics preparationsantibiotics preparationspharmaceutical preparations for treating diabetesantidiarrheals medicinesantifungal preparationsantihypertensivesantihistaminespharmaceutical preparations for the treatment of inflammationpharmaceutical preparations for the treatment of arthritisanthelminticscardiovascular agents for medical purposesallergy medicationsdermatologicalsdiureticsanimal feed supplementshuman growth hormonesanimal growth hormonespharmaceutical preparations for treating gynaecological conditionspharmaceutical preparations for treating haematological conditionslaxativesantiendotoxin antibodies for medical purposespharmaceutical agents affecting metabolismpediculicidal shampoospharmaceutical preparations for treating nausea and vertigosleeping pills/tabletsmedical preparations containing stimulants for treating neurological disorderstranquiliserspsychotherapeutic preparations in the nature of psychotropicsvitaminspharmaceutical preparations for the treatment of oncological diseases and disorderspreparations for use in the treatment of cancer and tumoursmedicinal creams for skin carepharmaceutical preparations for the treatment of immune system related diseases and disorderspharmaceutical preparations for the treatment of endocrine related diseases and disorders; enzymes for medical purposes; enzymes for veterinary purposes; bacterial preparations for medical purposes; bacterial preparations for veterinary purposes; antibodies for medical purposes; antibody-drug conjugates in the nature of antibodies for medical purposes; proteins for medical purposesfor human and veterinary purposes namely analgesics preparationsantibiotics preparationspharmaceutical preparations for treating diabetesantidiarrheals medicinesantifungal preparationsantihypertensivesantihistaminespharmaceutical preparations for the treatment of inflammationpharmaceutical preparations for the treatment of arthritisanthelminticscardiovascular agents for medical purposesallergy medicationsdermatologicalsdiureticsanimal feed supplementshuman growth hormonesanimal growth hormonespharmaceutical preparations for treating gynaecological conditionspharmaceutical preparations for treating haematological conditionslaxativesantiendotoxin antibodies for medical purposespharmaceutical agents affecting metabolismpediculicidal shampoospharmaceutical preparations for treating nausea and vertigosleeping pills/tabletsmedical preparations containing stimulants for treating neurological disorderstranquiliserspsychotherapeutic preparations in the nature of psychotropicsvitaminspharmaceutical preparations for the treatment of oncological diseases and disorderspreparations for use in the treatment of cancer and tumoursmedicinal creams for skin carepharmaceutical preparations for the treatment of immune system related diseases and disorderspharmaceutical preparations for the treatment of endocrine related diseases and disordersall of the aforesaid being protein based; nucleic acid sequences for medical and veterinary purposes; peptides for medical and veterinary purposessynthetic peptides for human and veterinary purposes namely analgesics preparationsantibiotics preparationspharmaceutical preparations for treating diabetesantidiarrheals medicinesantifungal preparationsantihypertensivesantihistaminespharmaceutical preparations for the treatment of inflammationpharmaceutical preparations for the treatment of arthritisanthelminticscardiovascular agents for medical purposesallergy medicationsdermatologicalsdiureticsanimal feed supplementshuman growth hormonesanimal growth hormonespharmaceutical preparations for treating gynaecological conditionspharmaceutical preparations for treating haematological conditionslaxativesantiendotoxin antibodies for medical purposespharmaceutical agents affecting metabolismpediculicidal shampoospharmaceutical preparations for treating nausea and vertigosleeping pills/tabletsmedical preparations containing stimulants for treating neurological disorderstranquiliserspsychotherapeutic preparations in the nature of psychotropicsvitaminspharmaceutical preparations for the treatment of oncological diseases and disorderspreparations for use in the treatment of cancer and tumoursmedicinal creams for skin carepharmaceutical preparations for the treatment of immune system related diseases and disorderspharmaceutical preparations for the treatment of endocrine related diseases and disordersall of the aforesaid being peptide based; polypeptides containing non-proteinogenic amino acids for medical and veterinary purposes namelysynthetic peptides for human and veterinary purposes namely analgesics preparationsantibiotics preparationspharmaceutical preparations for treating diabetesantidiarrheals medicinesantifungal preparationsantihypertensivesantihistaminespharmaceutical preparations for the treatment of inflammationpharmaceutical preparations for the treatment of arthritisanthelminticscardiovascular agents for medical purposesallergy medicationsdermatologicalsdiureticsanimal feed supplementshuman growth hormonesanimal growth hormonespharmaceutical preparations for treating gynaecological conditionspharmaceutical preparations for treating haematological conditionslaxativesantiendotoxin antibodies for medical purposespharmaceutical agents affecting metabolismpediculicidal shampoospharmaceutical preparations for treating nausea and vertigosleeping pills/tabletsmedical preparations containing stimulants for treating neurological disorderstranquiliserspsychotherapeutic preparations in the nature of psychotropicsvitaminspharmaceutical preparations for the treatment of oncological diseases and disorderspreparations for use in the treatment of cancer and tumoursmedicinal creams for skin carepharmaceutical preparations for the treatment of immune system related diseases and disorderspharmaceutical preparations for the treatment of endocrine related diseases and disordersall of the aforesaid being non-proteinogenic amino acid polypeptide based; polypeptides containing non-canonical amino acids for medical and veterinary purposes namelysynthetic peptides for human and veterinary purposes namely analgesics preparationsantibiotics preparationspharmaceutical preparations for treating diabetesantidiarrheals medicinesantifungal preparationsantihypertensivesantihistaminespharmaceutical preparations for the treatment of inflammationpharmaceutical preparations for the treatment of arthritisanthelminticscardiovascular agents for medical purposesallergy medicationsdermatologicalsdiureticsanimal feed supplementshuman growth hormonesanimal growth hormonespharmaceutical preparations for treating gynaecological conditionspharmaceutical preparations for treating haematological conditionslaxativesantiendotoxin antibodies for medical purposespharmaceutical agents affecting metabolismpediculicidal shampoospharmaceutical preparations for treating nausea and vertigosleeping pills/tabletsmedical preparations containing stimulants for treating neurological disorderstranquiliserspsychotherapeutic preparations in the nature of psychotropicsvitaminspharmaceutical preparations for the treatment of oncological diseases and disorderspreparations for use in the treatment of cancer and tumoursmedicinal creams for skin carepharmaceutical preparations for the treatment of immune system related diseases and disorderspharmaceutical preparations for the treatment of endocrine related diseases and disordersall of the aforesaid being non-canonical amino acid polypeptide based
Class 40
Biomanufacturing for others of nucleic acid sequencespolymersmaterials comprised of amino acids; biomanufacturing for others of nucleic acid sequencespolymersmaterials comprised of hydroxy acids; biomanufacturing for others of nucleic acid sequencespolymersmaterials comprised of amino acids and hydroxy acids; custom manufacture of unnatural and synthetic biomaterials in the nature of nucleic acid sequencespolymersand/or materials comprised of amino acids; custom manufacture of unnatural and synthetic biomaterials in the nature of nucleic acid sequencespolymersand/or materials comprised of hydroxy acids; custom manufacture of unnatural and synthetic biomaterials in the nature of nucleic acid sequencespolymersand/or materials comprised of amino acids and hydroxy acids
Class 42
Scientific research relating to medicines; scientific research relating to proteins and amino acid sequences for industrial and medical purposes; research and development in the pharmaceutical and biotechnology fields; scientific research and development for the pharmaceutical industry; scientific research and development in the field of biomaterials; scientific design and development of nucleic acid sequencesamino acid sequencesenzymesbacteriaproteins and biomaterials; scientific research in the field of DNA synthesis; scientific research in the field of protein synthesis; DNA sequencing technology research; bioplastics technology research; drug discovery services; research in the field of bioinformatics relating to design and development of nucleic acid sequencesamino acid sequencesenzymesbacteriaproteins and biomaterials; scientific research relating to genetic code expansion
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/13/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/25/2025
PUBO
PUBLISHED FOR OPPOSITION
11/25/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/19/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/27/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
10/27/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/27/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
10/27/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/27/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/23/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/23/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/23/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/26/2025
GNRT
NON-FINAL ACTION E-MAILED
06/26/2025
CNRT
NON-FINAL ACTION WRITTEN
06/26/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/02/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/02/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/27/2025
GNRT
NON-FINAL ACTION E-MAILED
03/27/2025
CNRT
NON-FINAL ACTION WRITTEN
03/27/2025
DOCK
ASSIGNED TO EXAMINER
03/19/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/26/2024
NWAP
NEW APPLICATION ENTERED
09/26/2024
Continuous trademark protection
Get notified about every new filing that threatens CONSTRUCTIVE BIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.